Abstract
This study investigates the association between immunotherapy and symptomatic radiation necrosis in patients with melanoma, non–small-cell lung cancer, or renal cell carcinoma and newly diagnosed brain metastases treated with stereotactic radiation therapy.
MeSH terms
-
Brain Neoplasms / immunology
-
Brain Neoplasms / secondary
-
Brain Neoplasms / therapy*
-
Carcinoma, Non-Small-Cell Lung / immunology
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Carcinoma, Non-Small-Cell Lung / therapy*
-
Carcinoma, Renal Cell / immunology
-
Carcinoma, Renal Cell / pathology
-
Carcinoma, Renal Cell / therapy*
-
Combined Modality Therapy
-
Female
-
Follow-Up Studies
-
Humans
-
Immunotherapy / adverse effects*
-
Kidney Neoplasms / immunology
-
Kidney Neoplasms / pathology
-
Kidney Neoplasms / therapy
-
Lung Neoplasms / immunology
-
Lung Neoplasms / pathology
-
Lung Neoplasms / therapy
-
Male
-
Melanoma / immunology
-
Melanoma / pathology
-
Melanoma / therapy*
-
Middle Aged
-
Prognosis
-
Radiation Injuries / etiology*
-
Radiation Injuries / pathology
-
Radiosurgery / adverse effects*
-
Survival Rate